Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung

Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):10-12. doi: 10.18502/ijaai.v19i(s1.r1).2849.

Abstract

No Abstract.

Keywords: No Keywords.

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus / drug effects*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / metabolism
  • Cytokines / drug effects
  • Dipeptidyl Peptidase 4 / drug effects
  • Dipeptidyl Peptidase 4 / metabolism
  • Dipeptidyl-Peptidase IV Inhibitors / pharmacology*
  • Drug Repositioning*
  • Humans
  • Inflammation / drug therapy
  • Inflammation / virology
  • Lung / drug effects
  • Lung / metabolism
  • Pandemics
  • Peptidyl-Dipeptidase A / drug effects
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / metabolism
  • SARS-CoV-2
  • Sitagliptin Phosphate / pharmacology*

Substances

  • Cytokines
  • Dipeptidyl-Peptidase IV Inhibitors
  • Dipeptidyl Peptidase 4
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
  • Sitagliptin Phosphate